See also this year's filing and all EDGAR filings for this company.
PDF Report 0001016504_2023_Integrated_Biopharma_INC.pdf
Logs
Graph
Absolute values for 0001016504, Integrated Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,626,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,910,000 |
| 3 | remainder_Assets | 6,714,000 |
| 4 | LiabilitiesCurrent | 5,263,000 |
| 5 | LiabilitiesNoncurrent | 1,412,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 49,880,137 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,796,865 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | -1,204,741 |
| 11 | remainder_Revenues | 56,873,800 |
| 12 | remainder_NetIncome | 180,424 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,250,000 |
| 1 | Liabilities | 6,675,000 |
| 2 | Expenses | 52,472,261 |
| 3 | Revenues | 56,873,800 |
| 4 | StockholdersEquity | 18,575,000 |
| 5 | NetIncome | 4,581,963 |
| 6 | ComprehensiveNetIncome | 4,581,963 |
| 7 | BaseVar | 70,725,742 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.82 |
| 9 | EconomicCapitalRatio | 3.57 |
Edgar->Model Mapping
Feature Distribution
Change over Time
